Cloix J F, Le Jossec M, Baud O, Pecquery R, Giudicelli Y, Dausse J P
Service de Biochimie de Paris-Ouest, UFR biomédicale des Saints-Pères, Paris.
C R Seances Soc Biol Fil. 1992;186(4):377-86.
Existing evidences indicate that a crossed regulation between alpha 2-adrenergic receptors and Na+/H+ exchanger(s) exists, that Na decreases the affinity of alpha 2-adrenergic receptors for agonists and antagonists, that intracellular Na+ and H+ ion concentrations regulate Na+/H+ exchanger activity, that intracellular pH controls the affinity of the alpha 2-adrenergic receptors for their agonists and antagonists. Alterations of alpha 2-adrenergic receptor densities and allosteric regulation by sodium have been demonstrated in sodium-dependent hypertension in rats. Increased Na+/H+ exchanger activity has been reported in genetic hypertension. Nevertheless, cosegregation experiments and human genetic polymorphism suggest that the exchanger could not be related to hypertension. We propose the following hypothesis: the increased Na+/H+ exchanger characteristic of hypertension could be secondary to the abnormalities of the alpha 2-adrenergic receptors found in hypertension, probably through the alteration of the sodium allosteric effect on these receptors.
现有证据表明,α2 - 肾上腺素能受体与钠/氢交换体之间存在交叉调节,钠会降低α2 - 肾上腺素能受体对激动剂和拮抗剂的亲和力,细胞内钠和氢离子浓度调节钠/氢交换体活性,细胞内pH值控制α2 - 肾上腺素能受体对其激动剂和拮抗剂的亲和力。在大鼠钠依赖性高血压中已证实α2 - 肾上腺素能受体密度的改变以及钠的变构调节。在遗传性高血压中已报道钠/氢交换体活性增加。然而,共分离实验和人类基因多态性表明该交换体与高血压无关。我们提出以下假设:高血压所特有的钠/氢交换体活性增加可能继发于高血压中发现的α2 - 肾上腺素能受体异常,可能是通过改变钠对这些受体的变构效应。